Tirzepatide injection pen on a counter beside a weekly planner with Wednesday circled, a glass of water and a bowl of microgreens

Tirzepatide for Weight Loss: How It Works and Who May Be a Candidate

October 08, 2026•3 min read

Quick answer: Tirzepatide is a once-weekly injection that activates two gut hormone receptors, GLP-1 and GIP, instead of one. That dual action produced an average weight loss of about 20% of body weight at the highest dose in clinical trials, compared with roughly 15% for semaglutide. It is approved for adults with obesity or overweight with a related condition, and it carries similar side effects. The best choice between the two depends on your metabolic picture, tolerance, and budget.

What is tirzepatide?

Tirzepatide is sold as Mounjaro (approved for type 2 diabetes) and Zepbound (approved for weight management and obstructive sleep apnea). Like semaglutide, it is injected once a week and started at a low dose that increases every four weeks.

How is it different from semaglutide?

Semaglutide mimics one hormone, GLP-1. Tirzepatide mimics two: GLP-1 and GIP. GIP appears to improve how fat tissue handles energy and may reduce the nausea that GLP-1 alone can cause. In head-to-head research, tirzepatide produced greater weight loss and larger improvements in blood sugar and triglycerides. Many patients also report fewer stomach side effects at equivalent doses, though this varies.

Who may be a candidate?

Zepbound is approved for adults with a BMI of 30 or higher, or 27 or higher with a condition such as high blood pressure, prediabetes, high cholesterol, or sleep apnea. The same exclusions apply as for semaglutide: a personal or family history of medullary thyroid cancer or MEN2, a history of pancreatitis, or pregnancy.

In practice, I lean toward tirzepatide for patients with significant insulin resistance, higher starting weights, or those who tried semaglutide and either plateaued or couldn't tolerate the nausea. I lean toward semaglutide when a patient has a longer track record of success on it or when a more gradual approach suits them.

What are the side effects?

Nausea, diarrhea, constipation, decreased appetite, and fatigue are the most common, usually mild and worst in the first weeks after a dose change. Less common risks include gallbladder disease, pancreatitis, and low blood sugar when combined with insulin or sulfonylureas. Because tirzepatide is potent, rapid weight loss and muscle loss are real concerns; protein and strength training are not optional.

How long before results?

Appetite changes begin within the first one to two weeks. Weight loss typically accelerates between months two and six as the dose rises. Trial participants continued losing weight through 72 weeks.

What affects the cost of tirzepatide in San Jose?

Cost depends on your dose, how long you stay on treatment, and what follow-up and labs are included. Ask for a clear, written price for your full plan before you start, including follow-up visits and labs.

What should I look for in a provider?

The same things as with any GLP-1: labs before starting, a muscle-protection plan, real follow-up, transparency about medication source, and a maintenance strategy. A good provider will also tell you honestly if tirzepatide is more medication than you need.

Dr. Hirmendi's Perspective

I think of semaglutide and tirzepatide as two tools with the same purpose and slightly different strengths. The question I ask is never "which drug is stronger" but "what is driving this patient's weight." For a woman in perimenopause with high fasting insulin and a stressful job, tirzepatide plus hormone support plus strength training often produces results neither would alone. For someone with milder insulin resistance, semaglutide at a modest dose may be all they need. The medication is the easy part. The evaluation is where the outcome is decided.

Ready to find out which option fits your body? Book a Discovery Call with our physician in San Jose. Call or text 408-649-1626 or book online at rejuvememedspa.com.

Written and medically reviewed by Mahwash Hirmendi, MD, MPH
Board-Certified Emergency Medicine · Board-Certified Wound Management · Functional Medicine Practitioner · 25+ years of clinical experience
Medical Director, RejuveMe Wellness Clinic, San Jose, California

blog author avatar

Mahwash Hirmendi, MD, MPH

Dr. Mahwash Hirmendi is a physician with more than 25 years of clinical experience. Board-certified in Emergency Medicine and Wound Management, with a Master of Public Health and training at Yale New Haven Hospital, Dr. Hirmendi also practices functional medicine. RejuveMe Medspa in San Jose was founded to offer physician-led care that brings together metabolic health, hormones, and regenerative aesthetics.

Instagram logo icon
Back to Blog